SEC FORM 4
$51,766.47
Maze Therapeutics, Inc. (MAZE)
Sale of 1,990 shares at $26.0133 per share.
Reporting Person Courtney Phillips · Officer Title GC and Corp. Secretary · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001782758-26-000008 · filed 2026-09-04 · View filing →